AI assistant
Sending…
BECTON DICKINSON & CO — Director's Dealing 2006
Feb 1, 2006
30003_dirs_2006-02-01_7e17fc23-ceaa-4a3b-bb43-8fa63e8e126c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2006-01-30
Reporting Person: COHEN GARY M (President - BD Medical)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-01-30 | Common Stock | M | 46594 | $29.34 | Acquired | 91656 | Direct |
| 2006-01-30 | Common Stock | S | 46594 | $64.06 | Disposed | 45062 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-01-30 | Employee Stock Option (right to buy) | $29.34 | M | 46594 | Disposed | 2008-01-26 | Common Stock (46594) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14346 | Indirect |
Footnotes
F1: The reported sale price reflects an average price for seventeen separate transactions. The actual sales prices for the transactions ranged from $64.00 through $64.16.
F2: Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of December 31, 2005.
F3: The option became 50% exercisable on January 26, 2000 and fully exercisable on January 26, 2001.
More from BECTON DICKINSON & CO
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 13
Capital/Financing Update
2026
May 12
Capital/Financing Update
2026
May 11
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 7
Share Issue/Capital Change
2026
May 7
Interim / Quarterly Report
2026
May 7